Presentation AHA 2024 Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement Presenter: Chisato Izumi November 17, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News TAVI Use Rising in Young US Patients, Yet Another Analysis Shows Yael L. Maxwell May 06, 2024
News Conference News STS 2024 Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3 Yael L. Maxwell February 09, 2024
News Conference News STS 2024 TAVI, SAVR Almost Equally Performed in California Patients Under 60 Yael L. Maxwell February 01, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024